Remove Drug Trials Remove Pharmaceuticals Remove Pharmacokinetics Remove Regulations
article thumbnail

What are the top disease areas for clinical drug trials?

Drug Discovery World

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, according to a recent report by analytics company Phesi. The approval was based on results from the PROpel Phase III trial, however, the drug was rejected by UK regulator NICE because it requires expensive genetic testing.

Trials 130
article thumbnail

Advanced 3D cell-based technologies

Drug Target Review

This major shift to the orthodox tradition of using animal experiments in drug testing dates back the Aristotle’s time and cemented 80 years ago with initial federal mandate of drug safety regulation of 1938. These guidelines drive the legitimacy of the models towards regulatory approval.